Liraglutide
SCALE™ Insulin
Novo Nordisk · Phase 3 · Completed · Enrollment 396
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| liraglutide 3.0 mg | Obesity or overweight | 3.0 mg | 56 | Efficacy | n/r |
| Placebo | Obesity or overweight | n/r | 56 | Efficacy | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Liraglutide
Novo Nordisk · Phase 3 · Completed · Enrollment 396
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| liraglutide 3.0 mg | Obesity or overweight | 3.0 mg | 56 | Efficacy | n/r |
| Placebo | Obesity or overweight | n/r | 56 | Efficacy | n/r |